Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: AIDS Behav. 2021 Mar 31;25(10):3413–3424. doi: 10.1007/s10461-021-03248-2

Table 3.

PrEP knowledge

Pre-
training
(T1)
Post-
training
(T2)*
1 M follow-
up (T3)
How effective is PrEP? 61.1% 91.7% 89.2%
About how many people are using PrEP worldwide? 32.5% 77.1% 58.0%
Out of 100 PrEP users, about how many would you expect to experience common side effects such as headache, nausea or weight loss? 49.7% 97.5% 87.9%
How often should someone see a healthcare provider to monitor medication side effects, lab bloodwork, and STIs once they are using PrEP? 53.5% 91.7% 79.0%
For PrEP users, which parts of their bodies should be tested for gonorrhea and chlamydia regularly? 66.2% 89.8% 86.0%
One should not drink alcohol while on PrEP use. True or false? 21.0% 93.6% 89.8%
Does TDF/FTC have approval by the China FDA to be used as PrEP in China 17.2% 77.1% 66.2%
PrEP knowledge score M (SD) M (SD) M (SD)
3.78 (1.28) 6.25 (1.00) 5.65 (1.12)

M: mean; SD: standard deviation.

Analyses restricted to participants who had heard of PrEP prior to T1 and completed all three surveys (n=157).

*

We used McNemar’s test to compare each item’s correct response rate at T2 versus T1. All increases were significant at p<0.0001, results not shown in the table.